236 related articles for article (PubMed ID: 16165720)
1. Non-invasive monitoring of oxidant stress in alcoholic liver disease.
Pemberton PW; Smith A; Warnes TW
Scand J Gastroenterol; 2005 Sep; 40(9):1102-8. PubMed ID: 16165720
[TBL] [Abstract][Full Text] [Related]
2. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
3. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
Koivisto H; Hietala J; Niemelä O
Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
[TBL] [Abstract][Full Text] [Related]
4. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A
J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue metabolism and alcohol intake in alcoholic liver disease.
Niemelä O; Risteli J; Blake JE; Risteli L; Compton KV; Orrego H
Alcohol Alcohol Suppl; 1991; 1():351-5. PubMed ID: 1845562
[TBL] [Abstract][Full Text] [Related]
7. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits.
Chang CY; Chen JY; Ke D; Hu ML
Nutrition; 2005 Oct; 21(10):987-93. PubMed ID: 16157235
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood.
Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D
Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study.
Abilés J; de la Cruz AP; Castaño J; Rodríguez-Elvira M; Aguayo E; Moreno-Torres R; Llopis J; Aranda P; Argüelles S; Ayala A; de la Quintana AM; Planells EM
Crit Care; 2006; 10(5):R146. PubMed ID: 17040563
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and antioxidant status in patients with alcoholic liver disease.
Masalkar PD; Abhang SA
Clin Chim Acta; 2005 May; 355(1-2):61-5. PubMed ID: 15820479
[TBL] [Abstract][Full Text] [Related]
12. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
13. Blood oxidative stress markers are unreliable markers of hepatic steatosis.
Bonnefont-Rousselot D; Ratziu V; Giral P; Charlotte F; Beucler I; Poynard T;
Aliment Pharmacol Ther; 2006 Jan; 23(1):91-8. PubMed ID: 16393285
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease.
Jain SK; Pemberton PW; Smith A; McMahon RF; Burrows PC; Aboutwerat A; Warnes TW
J Hepatol; 2002 Jun; 36(6):805-11. PubMed ID: 12044532
[TBL] [Abstract][Full Text] [Related]
15. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
16. Oxidative mechanisms in the pathogenesis of alcoholic liver disease.
Albano E
Mol Aspects Med; 2008; 29(1-2):9-16. PubMed ID: 18045675
[TBL] [Abstract][Full Text] [Related]
17. Status of blood antioxidant enzymes in alcoholic cirrhosis.
Chari S; Gupta M
Indian J Physiol Pharmacol; 2003 Jul; 47(3):343-6. PubMed ID: 14723322
[TBL] [Abstract][Full Text] [Related]
18. Oxidant stress in type I autoimmune hepatitis: the link between necroinflammation and fibrogenesis?
Pemberton PW; Aboutwerat A; Smith A; Burrows PC; McMahon RF; Warnes TW
Biochim Biophys Acta; 2004 Aug; 1689(3):182-9. PubMed ID: 15276644
[TBL] [Abstract][Full Text] [Related]
19. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
20. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
